The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 28, 2017

Filed:

Mar. 03, 2014
Applicant:

Research Corporation Technologies, Inc., Tucson, AZ (US);

Inventors:

Kurt R. Gehlsen, Tucson, AZ (US);

Timothy David Jones, Cambridgeshire, GB;

Francis Joseph Carr, Aberdeenshire, GB;

Arron Hearn, Cambridgeshire, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/38 (2006.01); A61K 39/00 (2006.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0002 (2013.01); C07K 14/38 (2013.01); C12N 9/22 (2013.01); C12Y 301/2701 (2013.01); A61K 2039/572 (2013.01); C07K 2319/33 (2013.01);
Abstract

The present application relates to modified T cell epitopes derived from fungal ribotoxins, including a-sarcin, clavin, gigantin, mitogillin, and restrictocin, as well as modified ribotoxin molecules comprising one or more of the modified epitopes. The modified ribotoxin molecules inhibit protein synthesis, like the wild type ribotoxins, but exhibit reduced immunogenicity as compared to the corresponding wild type ribotoxin. Another aspect relates to a fusion protein which comprises a modified ribotoxin fused or conjugated or otherwise linked to a targeting molecule that is effective for binding a target of interest. Another aspect relates to the use of the modified ribotoxin or fusion protein for treating or managing a disease or condition.


Find Patent Forward Citations

Loading…